Institutional Ownership Pacific Biosciences Of California, Inc. (PACB)
This table provides information about the institutional ownership of Pacific Biosciences Of California, Inc. (PACB). We have compiled data on the 293 institutions that hold shares in the stock, with a total of 253 Million shares, which have been reported (via 13F filing form) to have a value of $453 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Cathie Wood
Ark Investment Management LLC | St. Petersburg, Fl
|
Apr 18, 2024 Q1 2024 |
33,290,137
shares
|
$59.6 Million
0.89% of portfolio
|
Q1 2024
Reduced 3.52%
|
|
Vanguard Group Inc
Valley Forge, PA |
May 10, 2024 Q1 2024 |
26,606,485
shares
|
$47.6 Million
0.0% of portfolio
|
Q1 2024
Reduced 0.68%
|
|
Black Rock Inc.
New York, NY |
May 10, 2024 Q1 2024 |
23,394,984
shares
|
$41.9 Million
0.0% of portfolio
|
Q1 2024
Reduced 5.06%
|
|
Madrone Advisors, LLC
Menlo Park, CA |
May 14, 2024 Q1 2024 |
17,591,915
shares
|
$31.5 Million
9.04% of portfolio
|
Q4 2023
Added 7.16%
|
|
Nikko Asset Management Americas, Inc.
|
May 02, 2024 Q1 2024 |
12,824,385
shares
|
$23 Million
0.48% of portfolio
|
Q1 2024
Reduced 2.85%
|
|
Sumitomo Mitsui Trust Holdings, Inc.
|
Apr 19, 2024 Q1 2024 |
12,824,385
shares
|
$23 Million
0.03% of portfolio
|
Q1 2024
Reduced 2.85%
|
|
Edmond De Rothschild Holding S.A.
Chambesy, V8 |
May 08, 2024 Q1 2024 |
10,507,287
shares
|
$18.8 Million
0.67% of portfolio
|
Q1 2024
Added 955.48%
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
May 15, 2024 Q1 2024 |
8,397,820
shares
|
$15 Million
0.02% of portfolio
|
Q1 2024
Added 8.31%
|
|
Jackson Square Partners, LLC
San Francisco, CA |
May 08, 2024 Q1 2024 |
7,184,313
shares
|
$12.9 Million
1.13% of portfolio
|
Q1 2024
Reduced 25.97%
|
|
Deep Track Capital, LP
Greenwich, CT |
May 15, 2024 Q1 2024 |
7,000,000
shares
|
$12.5 Million
0.87% of portfolio
|
Q4 2023
Added 16.67%
|
|
Macquarie Group LTD
Australia, C3 |
May 14, 2024 Q1 2024 |
6,638,910
shares
|
$11.9 Million
0.03% of portfolio
|
Q1 2024
Added 33.54%
|
|
State Street Corp
Boston, MA |
May 15, 2024 Q1 2024 |
5,768,887
shares
|
$10.3 Million
0.0% of portfolio
|
Q1 2024
Added 2.57%
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2024 Q1 2024 |
5,642,779
shares
|
$10.1 Million
0.0% of portfolio
|
Q1 2024
Added 2.29%
|
|
Bellevue Group Ag
Kuesnacht, V8 |
May 15, 2024 Q1 2024 |
4,592,251
shares
|
$8.22 Million
0.27% of portfolio
|
Q1 2024
Reduced 37.24%
|
|
Farallon Capital Management LLC
San Francisco, CA |
May 24, 2024 Q1 2024 |
3,772,452
shares
|
$6.75 Million
0.07% of portfolio
|
Q1 2024
Reduced 39.07%
|
|
Dimensional Fund Advisors LP
Austin, TX |
May 10, 2024 Q1 2024 |
3,434,468
shares
|
$6.15 Million
0.0% of portfolio
|
Q1 2024
Added 12.34%
|
|
Capital World Investors
Los Angeles, CA |
May 14, 2024 Q1 2024 |
3,390,000
shares
|
$6.07 Million
0.0% of portfolio
|
Q1 2021
Reduced 37.75%
|
|
Capital International Investors
Los Angeles, CA |
May 14, 2024 Q1 2024 |
3,113,749
shares
|
$5.57 Million
0.0% of portfolio
|
Q3 2023
Reduced 26.14%
|
|
Vk Services, LLC
Menlo Park, CA |
May 15, 2024 Q1 2024 |
2,632,784
shares
|
$4.71 Million
3.32% of portfolio
|
Q4 2023
New holding
|
|
Northern Trust Corp
Chicago, IL |
May 14, 2024 Q1 2024 |
2,542,897
shares
|
$4.55 Million
0.0% of portfolio
|
Q1 2024
Reduced 5.74%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
May 15, 2024 Q1 2024 |
2,414,121
shares
|
$4.32 Million
0.0% of portfolio
|
Q1 2024
New holding
|
|
Goldman Sachs Group Inc
New York, NY |
May 15, 2024 Q1 2024 |
2,206,006
shares
|
$3.95 Million
0.0% of portfolio
|
Q1 2024
Added 38.65%
|
|
Eagle Health Investments LP
Greenwich, CT |
May 14, 2024 Q1 2024 |
2,167,021
shares
|
$3.88 Million
1.51% of portfolio
|
Q1 2024
Added 42.31%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
May 08, 2024 Q1 2024 |
1,987,519
shares
|
$3.56 Million
0.0% of portfolio
|
Q1 2024
Added 1.05%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
May 15, 2024 Q1 2024 |
1,955,382
shares
|
$3.5 Million
0.0% of portfolio
|
Q1 2024
Reduced 45.67%
|